What is specialty pharmacy and why does it matter for employers?

Specialty pharmacy refers to high-cost, complex medications — biologics, oncology drugs, and treatments for rare conditions — that typically require special handling, storage, or administration. Specialty drugs now account for 50–55% of total pharmacy spend for most self-funded employers despite representing only 1–2% of prescriptions, making specialty pharmacy management the single highest-impact area for pharmacy cost control.

What is a specialty pharmacy carve-out?

A specialty pharmacy carve-out separates specialty drug management from the main PBM contract, allowing employers to direct specialty prescriptions to an independent specialty pharmacy or carve-out vendor. Carve-outs typically achieve 15–30% savings on specialty drug costs by eliminating the PBM's specialty pharmacy markup and accessing better manufacturer pricing.

What is white bagging and how does it reduce specialty drug costs?

White bagging is a strategy where specialty drugs administered in a physician's office or infusion center are dispensed by a specialty pharmacy and shipped directly to the provider, rather than purchased and billed by the provider at a significant markup. White bagging eliminates the hospital or physician markup on specialty drugs, which can be 200–400% above acquisition cost.

What is site-of-care optimization for specialty drugs?

Site-of-care optimization redirects specialty drug infusions from high-cost hospital outpatient settings to lower-cost alternatives like physician offices, ambulatory infusion centers, or home infusion. The same drug and clinical care can cost 60–80% less outside a hospital outpatient setting. Employers can implement site-of-care programs through their PBM, TPA, or a dedicated specialty pharmacy vendor.

How do employers evaluate specialty pharmacy vendors?

Employers should evaluate specialty pharmacy vendors on net drug cost (after rebates and discounts), clinical support programs, patient adherence rates, prior authorization management, specialty drug pipeline management, and integration with the main PBM. Independent specialty pharmacy vendors like Rightway, Lumicera, and Shields Health Solutions offer employer-focused programs with transparent pricing.

Specialty

Specialty Pharmacy Strategy for Self-Funded Employers

Specialty drugs represent 2–3% of prescriptions but 50–60% of pharmacy costs — and that share is growing. Managing specialty pharmacy is the single highest-impact pharmacy cost-containment opportunity for most employers.

Key specialty pharmacy strategies

Specialty pharmacy carve-out: Separate specialty drug management from your PBM and contract with an independent specialty pharmacy that offers better pricing and clinical management.

White bagging: Require specialty drugs administered in a clinical setting to be dispensed by a specialty pharmacy rather than purchased by the hospital at inflated prices.

Site-of-care optimization: Move infused specialty drugs from hospital outpatient settings (where hospitals charge 2–4× more) to home infusion or physician office settings.

Biosimilar adoption: Actively promote biosimilar alternatives to branded biologics. Biosimilars can reduce specialty drug costs by 20–40%.

Clinical management programs: Ensure specialty drug patients are on the right drug, at the right dose, with appropriate monitoring — reducing waste and improving outcomes.

Related tools

Specialty Pharmacy Vendor Comparison

Compare specialty pharmacy carve-out programs on cost, access, and clinical support.

PBM Comparison Tool

Evaluate PBMs on specialty drug management and carve-out flexibility.

PBM Savings Calculator

Model specialty drug savings from site-of-care optimization and carve-out programs.

Compare specialty pharmacy vendors ← Back to hub